Shannon Puhalla, MD | Authors


Palbociclib Combined With Fulvestrant in Relapsed Metastatic HR+/HER2- Breast Cancer

July 01, 2015

Shannon Puhalla, MD, assistant professor of medicine, Division of Hematology/Oncology, University of Pittsburgh, discusses a phase III study examining the combination of palbociclib and fulvestrant for the treatment of patients with relapsed metastatic hormone receptor-positive, HER2-negative breast cancer.